These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9636563)

  • 1. Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
    Samuel D; Bismuth H; Boillot O; Ducerf C; Baulieux J; Gugenheim J; Baldini E; Launois B; Messner M; Wolf P; Ellero E; Domergue J; Pageaux J; Cherqui D; Duvoux C; Durand F; Belghiti J; Calmus Y; Massault PP; Neau-Cransac M; Saric J; LeTreut Y; Campan P
    Transplant Proc; 1998 Jun; 30(4):1394-6. PubMed ID: 9636563
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation.
    Salizzoni M; Cavallari A; Risaliti A; Filipponi F; Gerunda GE; Forti D; Fassati LR; Cillo U; Castagneto M; Valente U; Tisone G
    Transplant Proc; 2001 May; 33(3):2258-62. PubMed ID: 11377521
    [No Abstract]   [Full Text] [Related]  

  • 3. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 4. Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
    Boillot O; Baulieux J; Wolf P; Messner M; Cherqui D; Gugenheim J; Pageaux G; Belghiti J; Calmus Y; Le Treut Y; Neau-Cransac M; Samuel D
    Clin Transplant; 2001 Jun; 15(3):159-66. PubMed ID: 11389705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
    Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
    [No Abstract]   [Full Text] [Related]  

  • 6. Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation.
    Jonas S; Guckelberger O; Bechstein WO; Berg T; Müller AR; Platz KP; Tullius SG; Settmacher U; Steinmüller T; Hopf U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2179-81. PubMed ID: 9723433
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
    Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
    Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
    [No Abstract]   [Full Text] [Related]  

  • 8. Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
    Langrehr JM; Klupp J; Junge G; Jonas S; Neuhaus R; Bechstein WO; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2330-1. PubMed ID: 11377549
    [No Abstract]   [Full Text] [Related]  

  • 9. Low incidence of acute cellular rejection in liver transplantation with Neoral.
    Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H
    Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus is effective in both dual and triple regimens after liver transplantation.
    Serrano J; García González M; Gómez M; Ortiz de Urbina J; López Cillero P; San Juan F; Parrilla P; Herrero JI
    Transplant Proc; 2002 Aug; 34(5):1529-30. PubMed ID: 12176469
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation.
    Langrehr JM; Klupp J; Pfitzmann R; Neumann U; Lohmann R; Jonas S; Neuhaus R; Steinmüller T; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1520. PubMed ID: 11267404
    [No Abstract]   [Full Text] [Related]  

  • 12. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
    McDiarmid S; Goss J; Seu P; Shackleton C; Vargas J; Ament M; Busuttil R
    Transplant Proc; 1998 Jun; 30(4):1397-8. PubMed ID: 9636564
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
    Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
    Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
    Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract]   [Full Text] [Related]  

  • 16. Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation.
    Pirenne J; Aerts R; Koshiba T; Van Gelder F; Roskams T; Nevens F; Fevery J
    Transplant Proc; 2001; 33(1-2):1505. PubMed ID: 11267396
    [No Abstract]   [Full Text] [Related]  

  • 17. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L; Figueras J; Ramos E; Baliellas C; Torras J; Rafecas A; Fabregat J; Lama C; Ibañez L; Jaurrieta E
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation.
    Lipson DA; Palevsky HI; Kotloff RM; Edelman J
    Transplant Proc; 1998 Jun; 30(4):1505-7. PubMed ID: 9636612
    [No Abstract]   [Full Text] [Related]  

  • 20. Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
    Rossi G; Reggiani P; Orsenigo R; Leoni L; Caccamo L; Doglia M; Gatti S; Maggi U; Paone G; Galmarini D; Fassati LR
    Transplant Proc; 1998 Jun; 30(4):1391-3. PubMed ID: 9636562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.